Verapamil is a potential therapy for hypoglycaemic brain injury
Nat Rev Endocrinol
.
2018 Aug;14(8):443-444.
doi: 10.1038/s41574-018-0056-7.
Authors
Janice J Hwang
1
,
Robert S Sherwin
2
Affiliations
1
Division of Endocrinology, Yale School of Medicine, New Haven, CT, USA.
2
Division of Endocrinology, Yale School of Medicine, New Haven, CT, USA. Robert.sherwin@yale.edu.
PMID:
29967401
DOI:
10.1038/s41574-018-0056-7
No abstract available
Publication types
Comment
MeSH terms
Brain
Brain Injuries*
Cognitive Dysfunction*
Humans
Hypoglycemia*
Hypoglycemic Agents
Verapamil
Substances
Hypoglycemic Agents
Verapamil